The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Structure-based maximal affinity model predicts small-molecule druggability
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · cited 1×
“The current method is meant to address only the specified binding site and does not take into account the possibility of substantial flexibility or inhibition at allosteric pockets, both of which are important considerations in drug desig”
MethodStructural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644 · cited 1×
“This is likely due to underestimation of the contribution of electrostatic interactions, as statins have a conserved glutaminyl group that makes numerous hydrogen-bond and ion-pair interactions to the protei”
BackgroundThe development of imatinib as a therapeutic agent for chronic myeloid leukemia
Deininger, M., Buchdunger, E., & Druker, B. J. (2005) · Blood · doi:10.1182/blood-2004-08-3097 · Cited by 1,253
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
Schachter, M. (2005) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00299.x · Cited by 1,211
Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., Tai, C. Y., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963036t · Cited by 1,100
Liang, J., Woodward, C., & Edelsbrunner, H. (1998) · Protein Science · doi:10.1002/pro.5560070905 · Cited by 1,057
Cited by
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Identifying and Characterizing Binding Sites and Assessing Druggability
Halgren, T. A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800324m · Cited by 1,759
Fpocket: An open source platform for ligand pocket detection
Le Guilloux, V., Schmidtke, P., & Tuffery, P. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-168 · Cited by 1,653
Prediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,147
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
Gaussian interaction profile kernels for predicting drug–target interaction
van Laarhoven, T., Nabuurs, S. B., & Marchiori, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr500 · Cited by 934
Luo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., & Zeng, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00680-8 · Cited by 916
Drug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
Supervised prediction of drug–target interactions using bipartite local models
Bleakley, K., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 628
Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs
Zolotovskaia, M. A., Sorokin, M. I., Emelianova, A. A., Borisov, N. M., Kuzmin, D. V., Borger, P., Garazha, A. V., & Buzdin, A. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00001 · Cited by 531
He, T., Heidemeyer, M., Ban, F., Cherkasov, A., & Ester, M. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0209-z · Cited by 509
Combining Global and Local Measures for Structure-Based Druggability Predictions
Volkamer, A., Kuhn, D., Grombacher, T., Rippmann, F., & Rarey, M. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200454v · Cited by 496
Similarity-based machine learning methods for predicting drug–target interactions: a brief review
Ding, H., Takigawa, I., Mamitsuka, H., & Zhu, S. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbt056 · Cited by 427
Gönen, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts360 · Cited by 383
Talevi, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00205 · Cited by 381
Binding MOAD (Mother Of All Databases)
Hu, L., Benson, M. L., Smith, R. D., Lerner, M. G., & Carlson, H. A. (2005) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20512 · Cited by 328
Drugging Membrane Protein Interactions
Yin, H., & Flynn, A. D. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-092115-025322 · Cited by 339
The Thermodynamics of Protein–Ligand Interaction and Solvation: Insights for Ligand Design
Olsson, T. S. G., Williams, M. A., Pitt, W. R., & Ladbury, J. E. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.073 · Cited by 334
Zhang, Z., Li, Y., Lin, B., Schroeder, M., & Huang, B. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr331 · Cited by 332
Schmidtke, P., & Barril, X. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100574m · Cited by 331
Zheng, X., Ding, H., Mamitsuka, H., & Zhu, S. (2013) · Proceedings of the 19th ACM SIGKDD international conference on Knowledge discovery and data mining · doi:10.1145/2487575.2487670 · Cited by 328
Kang, L., Chung, B. G., Langer, R., & Khademhosseini, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.003 · Cited by 325
Properties and identification of human protein drug targets
Bakheet, T. M., & Doig, A. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp002 · Cited by 324
Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization
Ezzat, A., Zhao, P., Wu, M., Li, X.-L., & Kwoh, C.-K. (2017) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2016.2530062 · Cited by 322
Ezzat, A., Wu, M., Li, X.-L., & Kwoh, C.-K. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby002 · Cited by 314
Predicting druggable binding sites at the protein–protein interface
Fuller, J. C., Burgoyne, N. J., & Jackson, R. M. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.009 · Cited by 310
Bioactive iridium and rhodium complexes as therapeutic agents
Leung, C.-H., Zhong, H.-J., Chan, D. S.-H., & Ma, D.-L. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.01.034 · Cited by 303
Analyzing the Topology of Active Sites: On the Prediction of Pockets and Subpockets
Volkamer, A., Griewel, A., Grombacher, T., & Rarey, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100241y · Cited by 300
Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features
He, Z., Zhang, J., Shi, X.-H., Hu, L.-L., Kong, X., Cai, Y.-D., & Chou, K.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009603 · Cited by 288
Smith, M. C., & Gestwicki, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.10 · Cited by 286
Assessing drug-likeness – what are we missing?
Vistoli, G., Pedretti, A., & Testa, B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.007 · Cited by 278
Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
Vidler, L. R., Brown, N., Knapp, S., & Hoelder, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300346w · Cited by 278
Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification
Zhao, S., & Li, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011764 · Cited by 277
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery
Pérot, S., Sperandio, O., Miteva, M. A., Camproux, A.-C., & Villoutreix, B. O. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.015 · Cited by 276
Targeting Protein–Protein Interactions for Therapeutic Intervention: A Challenge for the Future
Zinzalla, G., & Thurston, D. E. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.12 · Cited by 260
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
Sacchettini, J. C., Rubin, E. J., & Freundlich, J. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1816 · Cited by 256
Targeting Protein-Protein Interaction by Small Molecules
Jin, L., Wang, W., & Fang, G. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140028 · Cited by 195
State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Sheng, C., Dong, G., Miao, Z., Zhang, W., & Wang, W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00252d · Cited by 165
Thafar, M. A., Olayan, R. S., Ashoor, H., Albaradei, S., Bajic, V. B., Gao, X., Gojobori, T., & Essack, M. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00447-2 · Cited by 143
Network-based characterization of drug-regulated genes, drug targets, and toxicity
Kotlyar, M., Fortney, K., & Jurisica, I. (2012) · Methods · doi:10.1016/j.ymeth.2012.06.003 · Cited by 92
Shigdel, U. K., Lee, S.-J., Sowa, M. E., Bowman, B. R., Robison, K., Zhou, M., Pua, K. H., Stiles, D. T., Blodgett, J. A. V., Udwary, D. W., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006560117 · Cited by 80
Modulating Protein–Protein Interactions with Small Molecules: The Importance of Binding Hotspots
Thangudu, R. R., Bryant, S. H., Panchenko, A. R., & Madej, T. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.026 · Cited by 71
Benson, N., Matsuura, T., Smirnov, S., Demin, O., Jones, H. M., Dua, P., & van der Graaf, P. H. (2013) · Interface Focus · doi:10.1098/rsfs.2012.0071 · Cited by 20
The Basis for Target‐Based Virtual Screening: Protein Structures
Cole, J. C., Korb, O., Olsson, T. S. G., & Liebeschuetz, J. (2011) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633326.ch4 · Cited by 9
Metadata
- Authors
- Cheng, A. C., Coleman, R. G., Smyth, K. T., Cao, Q., Soulard, P., Caffrey, D. R., Salzberg, A. C., & Huang, E. S.
- Venue
- Nature Biotechnology
- Published
- 2007-01
- Volume
- 25
- Issue
- 1
- Pages
- 71-75
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2018408116
- Cited by
- 695
- References
- 28
- FWCI
- 33.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.